A legal CBD business can lose its card processor on a Monday and have no working checkout by Tuesday. The product is real, the customers are real, the money is clean. None of that matters when an underwriting team decides the category is too hot to handle.
Card networks classify CBD as high risk, and the pricing reflects that judgment. A typical CBD merchant pays 4% to 7% per transaction, compared to 1.5% to 2.9% for a standard e-commerce retailer. Large aggregators, PayPal and Stripe among them, turn most CBD accounts away at the door. That pushes sellers toward specialist processors who charge the premium rate and layer a rolling reserve on top of it, withholding 5% to 10% of sales for six months or longer. For a small brand operating on tight margins, that frozen capital can be the difference between running and not running.
The market itself is not small. Global CBD revenues hit an estimated $10.68 billion in 2025 and are projected to reach $12.60 billion in 2026. The payment infrastructure has simply not kept pace.
The Numbers Behind the Instability
Fees are uncomfortable but at least predictable. Account closure is not. A processor can shut down a CBD merchant after a routine review, hold the reserve for months, and offer little explanation. A single FDA warning letter about a health claim can trigger the same outcome, because acquirers treat any regulatory attention as an amplified risk signal. An operator that processed cards without incident for years can find itself locked out within a week.
Dispute ratios make the situation worse. On April 1, 2025, Visa consolidated five separate fraud and dispute monitoring programs into a single Acquirer Monitoring Program. The new combined threshold for excessive chargebacks sits at 2.2%, with a planned reduction toward 1.5% in 2026. Merchants who breach the limit pay $8 per disputed transaction and face possible removal from the network. Crucially, fraud reports and buyer-initiated disputes now count together toward that single ratio. A clean month on fraud cannot offset a bad month on disputes. CBD sellers already post higher dispute rates than average, partly because subscription billing and unfamiliar payment descriptors generate confusion that turns into chargebacks.
Where Crypto Actually Helps, and Where It Does Not
Crypto settles two specific problems at their source. Blockchain transactions do not route through card networks, so neither the high-risk classification nor the chargeback mechanic applies. A stablecoin payment settles without a reserve requirement and without a dispute ratio that inches toward a punishing threshold. For merchants whose main exposure is account termination and chargeback fees, that is a direct fix, not a workaround.
What crypto does not fix is equally worth stating plainly. Regulatory uncertainty around CBD health claims remains. Consumer familiarity with crypto checkout is still limited. Tax reporting on crypto receipts adds accounting overhead. The category's problems run deeper than payment rails, and switching settlement method solves only the slice that lives on those rails. Right now, for some CBD operators, that slice is the one that decides whether the business opens tomorrow.
This article is for informational purposes only and does not constitute financial or investment advice.
